Skip to main content
Top
Published in: BMC Nephrology 1/2021

Open Access 01-12-2021 | Case report

Atypical histological abnormalities in an adult patient with nephronophthisis harboring NPHP1 deletion: a case report

Authors: Maiko Akira, Hitoshi Suzuki, Arisa Ikeda, Masako Iwasaki, Daisuke Honda, Hisatsugu Takahara, Hisaki Rinno, Shigeki Tomita, Yusuke Suzuki

Published in: BMC Nephrology | Issue 1/2021

Login to get access

Abstract

Background

Nephronophthisis (NPHP) is a chronic tubular interstitial disorder that exhibits an autosomal recessive genetic form and causes progressive renal failure in children. Patients with NPHP rarely show urinary abnormalities, edema, or hypertension. Thus, NPHP is often detected only when renal failure becomes advanced. NPHP can be divided into three types based on the age of end-stage renal failure, i.e., infant type (approximately 5 years old), juvenile type (approximately 13–14 years old), and adolescent type (approximately 19 years old). Here, we report a case of NPHP diagnosed by genetic analysis at 26 years of age with atypical histological abnormalities.

Case presentation

A 26-year-old woman showed no growth disorders or urinary abnormalities in annual school physical examinations. However, at a check-up at 26 years old, she exhibited renal dysfunction (eGFR 26 mL/min/1.73 m2). Urine tests indicated low specific gravity of urine, but not proteinuria or microscopic hematuria. Urinary β2-microglobulin was high (805 μg/L), and renal biopsy was performed for definitive diagnosis. Histological findings showed no significant findings in glomeruli. However, moderate fibrosis was observed in the interstitial area, and moderate atrophy was observed in the tubules. There were no significant findings in immunofluorescence analysis, and no electron dense deposits were detected by electron microscopy. Although cyst-like expansion of the tubules was unclear, tubular atrophy was dominantly found in the distal tubule by cytokeratin 7 staining. Genetic analysis of the NPHP1 gene showed complete deletion of this gene, leading to a definitive diagnosis of NPHP.

Conclusions

NPHP is not merely a pediatric disease and is relatively high incidence in patients with adult onset end-stage of renal disease. In this case, typical histological abnormalities, such as cyst-like expansion of the tubular lesion, were not observed, and diagnosis was achieved by genetic analysis of the NPHP1 gene, which is responsible for the onset of NPHP. In patients with renal failure with tubular interstitial disease dominantly in the distal tubules, it is necessary to discriminate NPHP, even in adult cases.
Literature
1.
go back to reference Wolf MT. Nephronophthisis and related syndromes. Curr Opin Pediatr. 2015;7:201–11.CrossRef Wolf MT. Nephronophthisis and related syndromes. Curr Opin Pediatr. 2015;7:201–11.CrossRef
2.
go back to reference Potter DE, et al. Jr treatment of end-stage renal disease in children: a 15-year experience. Kidney Int. 1980;18:103–9.CrossRefPubMed Potter DE, et al. Jr treatment of end-stage renal disease in children: a 15-year experience. Kidney Int. 1980;18:103–9.CrossRefPubMed
3.
go back to reference Ala-Mello S, et al. Molecular studies in Finnish patients with familial juvenile nephronophthisis exclude a founder effect and support a common mutation causing mechanism. J Med Genet. 1998;35:279–83.CrossRefPubMedPubMedCentral Ala-Mello S, et al. Molecular studies in Finnish patients with familial juvenile nephronophthisis exclude a founder effect and support a common mutation causing mechanism. J Med Genet. 1998;35:279–83.CrossRefPubMedPubMedCentral
4.
go back to reference Tsang SH, Aycinena ARP, Sharma T. Ciliopathy: senior-Løken syndrome. Adv Exp Med Biol. 2018;1085:175–8.CrossRefPubMed Tsang SH, Aycinena ARP, Sharma T. Ciliopathy: senior-Løken syndrome. Adv Exp Med Biol. 2018;1085:175–8.CrossRefPubMed
5.
6.
go back to reference Krishnan R, Eley L, Sayer JA. Urinary concentration defects and mechanisms underlying nephronophthisis. Kidney Blood Press Res. 2008;31:152–62.CrossRefPubMed Krishnan R, Eley L, Sayer JA. Urinary concentration defects and mechanisms underlying nephronophthisis. Kidney Blood Press Res. 2008;31:152–62.CrossRefPubMed
7.
go back to reference Hildebrandt F, et al. A novel gene encoding an SH3 domain protein is mutated in nephronophthisis type 1. Nat Genet. 1997;17:149–53.CrossRefPubMed Hildebrandt F, et al. A novel gene encoding an SH3 domain protein is mutated in nephronophthisis type 1. Nat Genet. 1997;17:149–53.CrossRefPubMed
8.
go back to reference Sugimoto K, et al. Clinical and genetic characteristics of Japanese nephronophthisis patients. Clin Exp Nephrol. 2016;20:637–49.CrossRefPubMed Sugimoto K, et al. Clinical and genetic characteristics of Japanese nephronophthisis patients. Clin Exp Nephrol. 2016;20:637–49.CrossRefPubMed
9.
go back to reference Kitamura H. Gene mutation and morphological changes of MCKD and ADTKD. Japanese Soc Nephrol. 2018;60:1239–43. Kitamura H. Gene mutation and morphological changes of MCKD and ADTKD. Japanese Soc Nephrol. 2018;60:1239–43.
10.
go back to reference Mollet G, et al. The gene mutated in juvenile nephronophthisis type 4 encodes a novel protein that interacts with nephrocystin. Nat Genet. 2002;32:300–5.CrossRefPubMed Mollet G, et al. The gene mutated in juvenile nephronophthisis type 4 encodes a novel protein that interacts with nephrocystin. Nat Genet. 2002;32:300–5.CrossRefPubMed
12.
go back to reference Hildebrandt F, Zhou W. Nephronophthisis-associated ciliopathies. J Am Soc Nephrol. 2007;18:1855–71.CrossRefPubMed Hildebrandt F, Zhou W. Nephronophthisis-associated ciliopathies. J Am Soc Nephrol. 2007;18:1855–71.CrossRefPubMed
13.
go back to reference Mistry K, et al. Novel mutations in NPHP4 in a consanguineous family with histological findings of focal segmental glomerulosclerosis. Am J Kidney Dis. 2007;50:855–64.CrossRefPubMed Mistry K, et al. Novel mutations in NPHP4 in a consanguineous family with histological findings of focal segmental glomerulosclerosis. Am J Kidney Dis. 2007;50:855–64.CrossRefPubMed
14.
go back to reference Hoefele J, et al. Mutational analysis of the NPHP4 gene in 250 patients with nephronophthisis. Hum Mutat. 2005;25:411.CrossRefPubMed Hoefele J, et al. Mutational analysis of the NPHP4 gene in 250 patients with nephronophthisis. Hum Mutat. 2005;25:411.CrossRefPubMed
15.
go back to reference Hildebrandt F, Attanasio M, Otto E. Nephronophthisis: disease mechanisms of a ciliopathy. J Am Soc Nephrol. 2009;20:23–35.CrossRefPubMed Hildebrandt F, Attanasio M, Otto E. Nephronophthisis: disease mechanisms of a ciliopathy. J Am Soc Nephrol. 2009;20:23–35.CrossRefPubMed
16.
go back to reference Srivastava S, et al. Many genes-one disease? Genetics of nephronophthisis (NPHP) and NPHP-associated disorders. Front Pediatr. 2017;5:287.CrossRefPubMed Srivastava S, et al. Many genes-one disease? Genetics of nephronophthisis (NPHP) and NPHP-associated disorders. Front Pediatr. 2017;5:287.CrossRefPubMed
17.
go back to reference Caridi G, et al. Clinical and molecular heterogeneity of juvenile nephronophthisis in Italy: insights from molecular screening. Am J Kidney Dis. 2000;35:44–51.CrossRefPubMed Caridi G, et al. Clinical and molecular heterogeneity of juvenile nephronophthisis in Italy: insights from molecular screening. Am J Kidney Dis. 2000;35:44–51.CrossRefPubMed
19.
go back to reference Bakkaloglu SA, et al. Diverse phenotypic expression of NPHP4 mutations in four siblings. Turk J Pediatr. 2014;56:423–6.PubMedPubMedCentral Bakkaloglu SA, et al. Diverse phenotypic expression of NPHP4 mutations in four siblings. Turk J Pediatr. 2014;56:423–6.PubMedPubMedCentral
Metadata
Title
Atypical histological abnormalities in an adult patient with nephronophthisis harboring NPHP1 deletion: a case report
Authors
Maiko Akira
Hitoshi Suzuki
Arisa Ikeda
Masako Iwasaki
Daisuke Honda
Hisatsugu Takahara
Hisaki Rinno
Shigeki Tomita
Yusuke Suzuki
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2021
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-021-02466-z

Other articles of this Issue 1/2021

BMC Nephrology 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.